4D Molecular Therapeutics. (4/30/18). "Press Release: 4DMT and Roche Expand Ophthalmology Partnership to Develop and Commercialize Multiple AAV Gene Therapy Products". Emeryville, CA. |
2018-04-30 |
Curetis N.V.. (4/30/18). "Press Release: Curetis Announces Change of the Composition of Its Supervisory Board. Dr. Holger Reithinger Resigns as Member of the Supervisory Board". Amsterdam, San Diego, CA & Holzgerlingen. |
2018-04-30 |
Curetis N.V.. (4/30/18). "Press Release: Curetis Publishes Full-Year 2017 Financial Results and Updated Guidance for 2018". Amsterdam & Holzgerlingen. |
2018-04-30 |
Bruker Corporation. (4/30/18). "Press Release: Bruker Introduces New NMR Technologies and Research Products". Orlando, FL. |
2018-04-30 |
Curetis N.V.. (4/27/18). "Press Release: Curetis to Raise EUR 4.1 Million in Equity Offering with Access to Additional USD 10 million in Equity Over 36 Months [Not for United States, Australia, Canada, Japan, or any other jurisdiction where unlawful]". A |
2018-04-27 |
Sanofi S.A.. (4/27/18). "Press Release: First-quarter 2018 Business EPS up 1.4% at CER". Paris. |
2018-04-27 |
Polyphor Ltd.. (4/27/18). "Press Release: Polyphor Launches IPO on SIX Swiss Exchange and Sets Price Range [These materials may not be published, distributed or transmitted in the United States, Canada, Australia or Japan. ]". |
2018-04-27 |
Omeicos Therapeutics GmbH. (4/27/18). "Press Release: Alexander Gebauer Joins Executive Board of Omeicos Therapeutics and Named CEO and Chairman of Omeicos Ophthalmics". Berlin & Boston, MA. |
2018-04-27 |
Zedira GmbH. (4/26/18). "Press Release: Dr. Falk Pharma and Zedira Announce Start of the Phase 2a Proof of Concept Study of ZED1227 for the Treatment of Celiac Disease". Freiburg & Darmstadt. |
2018-04-26 |
Neurimmune AG. (4/26/18). "Press Release: Neurimmune Appoints Fabian Buller as Chief Business Officer". Schlieren. |
2018-04-26 |
Eppendorf AG. (4/26/18). "Press Release: Ready-to-use, Synthetic Surface Cultureware for Human Induced Pluripotent Stem Cells (hiPSCs) Coming to Market". Hamburg. |
2018-04-26 |
Bruker Corporation. (4/26/18). "Press Release: Bruker Appoints Falko Busse as President of the Bruker BioSpin Group". Billerica, MA. |
2018-04-26 |
AiCuris Anti-infective Cures GmbH. (4/25/18). "Press Release: Approval of MSD’s Prevymis (letermovir) in Japan Triggers EUR 15 Million Milestone Payment for AiCuris". Wuppertal. |
2018-04-25 |
Pieris Pharmaceuticals, Inc.. (4/25/18). "Press Release: Pieris Pharmaceuticals Appoints Ann Barbier, M.D., Ph.D., to Its Board of Directors". Boston, MA. |
2018-04-25 |
Corvidia Therapeutics. (4/25/18). "Press Release: Corvidia Therapeutics Secures $60 Million in Series B Funding to Accelerate Clinical Work". Waltham, MA. |
2018-04-25 |
Freenome, Inc.. (4/24/18). "Press Release: Freenome and Biognosys Announce Collaboration to Improve Early-Cancer Detection and Treatment". South San Francisco, CA & Zurich. |
2018-04-24 |
Topas Therapeutics GmbH. (4/24/18). "Press Release: Topas Therapeutics and Boehringer Ingelheim Sign Multi-Year Collaboration and Option Agreement". Hamburg. |
2018-04-24 |
Eppendorf AG. (4/24/18). "Press Release: Fiscal Year 2017 – Eppendorf Continues to Generate Growth above the Market Average". Hamburg. |
2018-04-24 |
Sanofi S.A.. (4/24/18). "Press Release: Sanofi Head of Global R&D Elias Zerhouni to Retire; Company Names John Reed to Take Over on July 1". Paris. |
2018-04-24 |
IDT Biologika GmbH. (4/24/18). "Press Release: IDT Biologika Acquires Dr. Felgenträger, Located in the BioPharmaPark Dessau". Dessau-Roslau. |
2018-04-24 |
Eurofins Scientific. (4/24/18). "Press Release: Eurofins Revenues Grow +23% in Q1 2018 to EUR 839m". |
2018-04-24 |
Revolution Medicines, Inc.. (4/24/18). "Press Release: Revolution Medicines Raises $56 Million in Series B Financing". Redwood City, CA. |
2018-04-24 |
Probiodrug AG. (4/23/18). "Press Release: Probiodrug Appoints Dr. Ulrich Dauer as Chief Executive Officer". Halle (Saale). |
2018-04-23 |
Merck KGaA. (4/23/18). "Press Release: Merck Receives Patent for CRISPR Technology in China". Darmstadt. |
2018-04-23 |
MorphoSys AG. (4/23/18). "Press Release: MorphoSys Announces Closing of Nasdaq IPO through an ADS Offering and Exercise of the Underwriters' Option to Purchase Additional ADSs, Leading to Total Gross Proceeds of USD 239 million". Planegg. |
2018-04-23 |
Lead Discovery Center GmbH. (4/23/18). "Press Release: LDC – New Branch for Development of Therapeutic Antibodies in Munich". Dortmund & Munich. |
2018-04-23 |
Grünenthal GmbH. (4/23/18). "Press Release: Dr. Philip Just Larsen Appointed Chief Scientific Officer (CSO)". Aachen. |
2018-04-23 |
Mologen AG. (4/20/18). "Press Release: Chief Executive Officer of Mologen AG Will Not Extend Executive Board Mandate Expiring in October 2018 (Ad-hoc News)". Berlin. |
2018-04-20 |
Qiagen N.V.. (4/20/18). "Press Release: Qiagen Announces FDA Approval of PartoSure". Germantown, MD & Hilden. |
2018-04-20 |
Bruker Corporation. (4/20/18). "Press Release: Bruker Introduces Bologna Workflow for Rapid and Cost-Effective Clinical Microbiology Diagnosis of Bloodstream Infections with Broad Species Coverage". Madrid. |
2018-04-20 |
4SC AG. (4/19/18). "Press Release: Phase II Study of 4SC’s Resminostat in Biliary Tract Cancer in Japan Is Initiated". Planegg-Martinsried. |
2018-04-19 |
Altona Diagnostics GmbH. (4/19/18). "Press Release: Altona Diagnostics Launches CE-IVD marked AltoStar Molecular Diagnostic Workflow". Hamburg. |
2018-04-19 |
Qiagen N.V.. (4/19/18). "Press Release: Qiagen Announces European Launch of QIAstat-Dx, a Next Generation Platform for Syndromic Insights". Hilden & Germantown, MD. |
2018-04-19 |
Merck KGaA. (4/19/18). "Press Release: Merck to Sell Consumer Health to Procter & Gamble". Darmstadt. |
2018-04-19 |
Merck KGaA. (4/19/18). "Press Release: Merck, University of Cape Town and Medicines for Malaria Venture Join Forces to Feed the Antimalarial Pipeline". Darmstadt. |
2018-04-19 |
Curetis N.V.. (4/19/18). "Press Release: Curetis Launches CE-IVD Marked Unyvero Urinary Tract Infection (UTI) Cartridge at ECCMID 2018". Amsterdam, San Diego, CA & Holzgerlingen. |
2018-04-19 |
Idorsia Ltd.. (4/19/18). "Press Release: Idorsia Announces Financial Results for the First Quarter 2018". Allschwil. |
2018-04-19 |
Takeda Pharmaceutical Co. Ltd.. (4/19/18). "Press Release: Takeda Statement Regarding Shire plc [Not for release in any jurisdiction where violation of law]". Cambridge, MA & Osaka. |
2018-04-19 |
Novartis AG. (4/18/18). "Press Release: Sandoz Signs Agreement with Pear Therapeutics to Develop and Commercialize Prescription Digital Therapeutics for Patients with Substance Use Disorder and Opioid Use Disorders". Holzkirchen. |
2018-04-18 |
InterAx Biotech AG. (4/18/18). "Press Release: New Immune Oncology Drug Molecules Expected to Result from LeadXpro / InterAx Partnership". Villigen. |
2018-04-18 |
AiCuris Anti-infective Cures GmbH. (4/18/18). "Press Release: AiCuris and Max Planck Institute of Molecular Physiology Join Forces in the Field of Anti-infectives". Wuppertal & Dortmund. |
2018-04-18 |
MorphoSys AG. (4/18/18). "Press Release: MorphoSys Announces Pricing of Initial Public Offering of American Depositary Shares (ADSs) on Nasdaq". Planegg. |
2018-04-18 |
MorphoSys AG. (4/18/18). "Press Release: Ad hoc – MorphoSys Resolves a Capital Increase to Implement the Offering of 8,300,000 American Depositary Shares (ADS) in the United States". Planegg. |
2018-04-18 |
Ayoxxa Biosystems GmbH. (4/18/18). "Press Release: Ayoxxa Launches Lunaris Human 12-Plex Th17 Kit Expanding Its Portfolio for Fully Scalable Biomarker Analysis". Cologne. |
2018-04-18 |
ProBioGen AG. (4/18/18). "Press Release: ProBioGen Signs Second Contract Development Agreement with Tizona Therapeutics for Immuno-Oncology Antibody Project". Berlin. |
2018-04-18 |
Curetis N.V.. (4/18/18). "Press Release: Curetis – Novel Products and Study Data to Be Presented at ECCMID 2018". Amsterdam, San Diego, CA & Holzgerlingen. |
2018-04-18 |
Evotec AG. (4/18/18). "Press Release: Evotec and Bayer Advance Third Endometriosis Programme into Phase I Clinical Development". Hamburg. |
2018-04-18 |
Bruker Corporation. (4/17/18). "Press Release: Bruker Acquires nanoIR Company Anasys Instruments". Billerica, MA. |
2018-04-17 |
4SC AG. (4/17/18). "Press Release: 4SC at AACR – Broadened Clinical Options for 4SC-202". Planegg-Martinsried. |
2018-04-17 |
Bruker Corporation. (4/17/18). "Press Release: DKSH and Bruker AXS Sign Distribution Agreement for Asia Pacific". |
2018-04-17 |
Novaremed AG. (4/17/18). "Press Release: Novaremed Announces that It Has Raised CHF 4.4 Million. Phase 2b Study Planned for Lead Compound NRD.E1 in Diabetic Neuropathic Pain". Basel. |
2018-04-17 |
Oncgnostics GmbH. (4/16/18). "Press Release: Test for Uterine Cancer in Portugal. Biotech Firm Oncgnostics Grants Exclusive Licence for Cancer Screening Test". Lisbon & Jena. |
2018-04-16 |
Boehringer Ingelheim. (4/16/18). "Press Release: Boehringer Ingelheim and Lilly Announce an Academic Collaboration with University of Oxford to Investigate the Effects of Empagliflozin in People with Chronic Kidney Disease". Ingelheim & Indianapolis, IN. |
2018-04-16 |
Sartorius Stedim Biotech GmbH. (4/16/18). "Press Release: Sartorius Stedim Biotech and Penn State University Announce Partnership". University Park, PA & Göttingen. |
2018-04-16 |
Shimadzu Corporation. (4/16/18). "Press Release: Shimadzu’s New UV-1900 UV-VIS Spectrophotometer Offers the Industry's Fastest Level Scan Function and LabSolutions UV-Vis Control Software". |
2018-04-16 |
Randox Laboratories Ltd.. (4/16/18). "Press Release: Vivalytic – The All-in-One Solution for Molecular Diagnostics". |
2018-04-16 |
Deinove S.A.. (4/13/18). "Press Release: Deinove Takes on a Whole Dimension with the Acquisition of Morphochem’s Clinical-stage Antibiotic Compound". Montpellier. |
2018-04-13 |
Enterprise Therapeutics Ltd.. (4/12/18). "Press Release: Enterprise Therapeutics Raises £29 Million ($41 Million USD) Funding". Brighton. |
2018-04-12 |
Humedics GmbH. (4/12/18). "Press Release: The LiMAx Liver Capacity Test Is Now Commercially Available in Germany, Austria and the UK". Berlin & Paris. |
2018-04-12 |
Microsaic Systems plc. (4/12/18). "Press Release: Microsaic Signs Agreement with Knauer". |
2018-04-12 |
Evotec AG. (4/11/18). "Press Release: Evotec Forms Collaboration with Petra Pharma on INDiGO Platform". Hamburg. |
2018-04-11 |
4SC AG. (4/11/18). "Press Release: Yakult Honsha Recruits First Japanese Patient in 4SC’s Pivotal RESMAIN Study of Resminostat in CTCL". Planegg-Martinsried. |
2018-04-11 |
Boehringer Ingelheim. (4/11/18). "Press Release: Boehringer Ingelheim to Invest €65 Million in Avian Vaccines". Lyon. |
2018-04-11 |
Medigene AG. (4/11/18). "Press Release: Medigene Appoints Dr. Kai Pinkernell to the Executive Management Board as CMO/CDO". Planegg. |
2018-04-11 |
Curetis N.V.. (4/11/18). "Press Release: Curetis Establishes U.S. Scientific Advisory Board". Amsterdam, San Diego, CA & Holzgerlingen. |
2018-04-11 |
Analytik Jena AG. (4/11/18). "Press Release: Analytica 2018 – Analytik Jena Is Making AAS Technology Ready for Today’s Labs". Jena. |
2018-04-11 |
Roivant Sciences GmbH. (4/11/18). "Press Release: Arbutus and Roivant Launch Genevant Sciences with Industry-leading Platform to Develop Broad Range of RNA Therapeutics for Genetic Diseases". Cambridge, MA, Vancouver, BC & Basel. |
2018-04-11 |
MorphoSys AG. (4/10/18). "Press Release: MorphoSys Nominates New Candidates for Supervisory Board". Planegg. |
2018-04-10 |
Microsaic Systems plc. (4/10/18). "Press Release: Microsaic Systems Launches 4500 MiD for Point-of-need Mass Spectrometry at Analytica 2018". |
2018-04-10 |
Waters Corporation. (4/10/18). "Press Release: Waters New Acquity UPLC Plus Series Sets New Performance Benchmarks". Milford, MA. |
2018-04-10 |
Bruker Corporation. (4/10/18). "Press Release: Bruker Introduces the New CTX Portable XRF Analyzer". Munich. |
2018-04-10 |
Bruker Corporation. (4/10/18). "Press Release: Bruker Launches New FT-IR R&D Spectrometer INVENIO". Munich. |
2018-04-10 |
Centogene AG. (4/10/18). "Press Release: Centogene Expands Executive Team, Appoints Dr. Dirk Ehlers Chief Operating Officer". Rostock. |
2018-04-10 |
Lonza Group Ltd.. (4/10/18). "Press Release: Lonza Opens World’s Largest Dedicated Cell and Gene Therapy Manufacturing Facility in Pearland, Greater Houston, TX (USA)". Pearland, Greater Houston, TX. |
2018-04-10 |
AB Sciex (d/b/a Sciex). (4/10/18). "Press Release: Sciex Launches the Citrine Triple Quad MS/MS Systems in Europe, Bringing Maximal Speed and Sensitivity to Clinical Diagnostics Testing". Darmstadt. |
2018-04-10 |
Shimadzu Europe GmbH. (4/10/18). "Press Release: New Nexgen GC CAGC-100. 1/3 Less Large and Twice as Fast". |
2018-04-10 |
Biomax Informatics AG. (4/10/18). "Press Release: Biomax Informatics Software Licensed by Global Pharma Company, Boehringer Ingelheim, to Build a Target Discovery Knowledge Platform". Planegg. |
2018-04-10 |
Promethera Biosciences S.A.. (4/10/18). "Press Release: Promethera Biosciences Acquires Baliopharm AG to Strengthen its Therapeutic Strategy in NASH With a Unique Tumor Necrosis Factor Receptor 1 (TNF-R1) Antibody Drug Candidates". Mont-Saint-Guibert & B |
2018-04-10 |
Markes International Ltd.. (4/9/18). "Press Release: New Sample Preparation and Concentration Platform Marks a Major Advance in Automation of GC–MS Workflows". Llantrisant. |
2018-04-09 |
MorphoSys AG. (4/9/18). "Press Release (Ad hoc): MorphoSys Announces Launch of American Depositary Shares (ADS) Offering in the United States". |
2018-04-09 |
Argen-X N.V. (Argenx). (4/9/18). "Press Release: Argenx Appoints Keith Woods as Chief Operating Officer". Breda & Ghent. |
2018-04-09 |
Novartis AG. (4/9/18). "Press Release: Novartis Enters Agreement to Acquire AveXis Inc. for USD 8.7 bn to Transform Care in SMA and Expand Position as a Gene Therapy and Neuroscience Leader". Basel. |
2018-04-09 |
Agilent Technologies Inc.. (4/9/18). "Press Release: Agilent Highlights Lab Efficiency through Innovative Solutions at Analytica 2018". Santa Clara, CA. |
2018-04-09 |
Grünenthal GmbH. (4/9/18). "Press Release: Grünenthal and KU Leuven Join Forces to Develop an Innovative Non-opioid Pain Treatment". Aachen & Leuven. |
2018-04-09 |
Polyphor Ltd.. (4/9/18). "Press Release: Polyphor Announces Plans to IPO and List on SIX Swiss Exchange [These materials may not be published, distributed or transmitted in the United States, Canada, Australia or Japan. ]". |
2018-04-09 |
Analytik Jena AG. (4/9/18). "Press Release: Analytica 2018 – Analytik Jena Expands the Leading ICP-MS Series with a High-Performance Liquid Chromatography Module". Jena. |
2018-04-09 |
MorphoSys AG. (4/6/18). "Press Release: MorphoSys Announces Approval of Tremfya (Guselkumab) for the Treatment of Moderate to Severe Forms of Psoriasis and Psoriatic Arthritis in Japan". Planegg. |
2018-04-06 |
Roche. (4/6/18). "Press Release: Roche Completes Acquisition of Flatiron Health". Basel. |
2018-04-06 |
MAB Discovery GmbH. (4/5/18). "Press Release: EUROSTARS Grants Project Funding for SPARKLE Consortium". Neuried. |
2018-04-05 |
Actimed Therapeutics Ltd.. (4/5/18). "Press Release: Actimed Therapeutics Appoints Pharma Veteran Dr David Ebsworth as Chairman". Ascot. |
2018-04-05 |
Ferring Pharmaceuticals S.A.. (4/5/18). "Press Release: Ferring Acquires Innovative Biotechnology Company and Microbiome Pioneer Rebiotix Inc.". Saint-Prex & Roseville, MN. |
2018-04-05 |
Autolus Ltd.. (4/4/18). "Press Release: Autolus and Miltenyi Biotec Sign Strategic Supply Agreement". London. |
2018-04-04 |
Arvinas, LLC. (4/4/18). "Press Release: Arvinas Completes $55 Million Series C Financing to Advance Protein Degradation Platform". New Haven, CT. |
2018-04-04 |
AvroBio, Inc.. (4/4/18). "Press Release: AvroBio, Inc. Appoints Annalisa Jenkins to Its Board of Directors". Cambridge, MA. |
2018-04-04 |
Andera Partners. (4/4/18). "Press Release: EdRIP becomes Andera Partners. EdRIP Announced the Buyout of the Management Company by Its Employees, in Agreement with Its Majority Shareholder". Paris. |
2018-04-04 |
Boehringer Ingelheim. (4/4/18). "Press Release: Boehringer Ingelheim and OSE Immunotherapeutics Announce Global Immuno-Oncology Partnership to Develop a Pioneering Checkpoint Inhibitor for the Treatment of Advanced Solid Tumors". Ingelheim & Nantes. |
2018-04-04 |
Curetis N.V.. (4/4/18). "Press Release: Curetis’ Unyvero BCU Blood Culture Application Receives Approval from Singapore Health Sciences Authority". Amsterdam & Holzgerlingen. |
2018-04-04 |
Arsanis, Inc.. (4/4/18). "Press Release: Arsanis Out-Licenses Preclinical Stage E. coli Monoclonal Antibodies". Waltham, MA & Vienna. |
2018-04-04 |
Brainomix Ltd.. (4/3/18). "Press Release: Brainomix Secures £7m ($9.8m) Investment to Tackle Strokes with AI". Oxford. |
2018-04-03 |
Curetis N.V.. (4/3/18). "Press Release: Curetis Receives U.S. FDA De Novo Clearance of Unyvero System and Unyvero LRT Lower Respiratory Tract Infection Cartridge". Amsterdam, San Diego, CA & Holzgerlingen. |
2018-04-03 |